Press Releases
Press Releases
JB Pharma records revenue growth of 32% to INR 793 crores in Q3 FY23 Operating EBITDA grew by 26% to INR 193 crores
JB Pharma underlined its tested track record of being one of the fastest growing pharmaceutical companies in the subcontinent by announcing impressive numbers in the...
Press Releases
Medtronic LINQ Insertable Cardiac Monitor detects 10 times more atrial fibrillation in ischemic stroke patients at three years compared to standard of care
Medtronic announced late-breaking clinical data from the STROKE AF clinical study, which showed large and small vessel disease stroke patients had a 10-fold increase in...
Press Releases
Rural Hospitals Need to Adopt New Strategies to Overcome Healthcare Challenges
Rural hospitals should develop and implement strategies that will help them successfully navigate a challenging healthcare environment this year, says Jim Kendrick, president and CEO...
Press Releases
CareLineLive expands partnership with Mid and South Essex NHS Foundation Trust to release 60 hospital beds per day
CareLineLive, the all-in-one home care management software provider, has announced the expansion of its partnership with Mid and South Essex NHS Foundation Trust (MSEFT) to free...
Press Releases
Leading experts in the field of fertility gather for ANNO 2023, the first international conference by ART Fertility Clinics in India
The conference focused on how ART has made significant strides in patients' medical and clinical care over the past two decades. It also underscored the importance...
Press Releases
Emirates Health Services announces ‘Care AI’ and ‘Digital Twin’ projects
Emirates Health Services (EHS) has launched the ‘Care AI’ and ‘Digital Twin’ projects which are the first of its kind in the region while taking...
Press Releases
Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction For Its Investigational Celularity Tendon Wrap (CTW)
Celularity Inc. (“Celularity” or the “Company”), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced that, in response to its October 2022...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.